| Dr Julio M Sosa, MD | |
|
5641 W Maple Rd, West Bloomfield, MI 48322 | |
| (248) 538-3020 | |
| (248) 538-0892 |
| Full Name | Dr Julio M Sosa |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 31 Years |
| Location | 5641 W Maple Rd, West Bloomfield, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962480731 | NPI | - | NPPES |
| 4099870 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 4301061683 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Beaumont Hospital Royal Oak | Royal oak, MI | Hospital |
| Entity Name | Julio M. Sosa Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326349168 PECOS PAC ID: 8628264231 Enrollment ID: O20101122000928 |
News Archive
New research published in the journal Nature, could pave the way to world's first genetically modified human baby. The research involves making embryos with genes from one man and two women. There are hundreds or families around the world who are left childless or have serious ill babies because they carry genes for hereditary illnesses. This research may bring hope to such couples. According to scientists on the team, within the next three years these women will be able to avail such techniques. There has been skepticism regarding ethical issues attached to making of "designer babies".
Asparity Decision Solutions is pleased to announce that www.PlanSmartChoice.com will continue to be available free to all federal employees during the 2010 open season, which begins November 9, 2009.
Based on current trends, nearly 6.5 million Americans between the ages of 35 and 84 are expected to be diagnosed with knee osteoarthritis in the next 10 years, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.
Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect.
Durata Therapeutics today announced the closing of its initial public offering of 8,625,000 shares of common stock at a public offering price of $9.00 per share, before underwriting discounts, including 1,125,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares at the public offering price, less the underwriting discount.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Julio M Sosa, MD 5641 W Maple Rd, West Bloomfield, MI 48322-3714 Ph: (248) 538-3020 | Dr Julio M Sosa, MD 5641 W Maple Rd, West Bloomfield, MI 48322 Ph: (248) 538-3020 |
News Archive
New research published in the journal Nature, could pave the way to world's first genetically modified human baby. The research involves making embryos with genes from one man and two women. There are hundreds or families around the world who are left childless or have serious ill babies because they carry genes for hereditary illnesses. This research may bring hope to such couples. According to scientists on the team, within the next three years these women will be able to avail such techniques. There has been skepticism regarding ethical issues attached to making of "designer babies".
Asparity Decision Solutions is pleased to announce that www.PlanSmartChoice.com will continue to be available free to all federal employees during the 2010 open season, which begins November 9, 2009.
Based on current trends, nearly 6.5 million Americans between the ages of 35 and 84 are expected to be diagnosed with knee osteoarthritis in the next 10 years, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.
Within seven days of vaccination, a blood test early after vaccination can predict whether vaccines based on living, modified viruses have had the desired effect.
Durata Therapeutics today announced the closing of its initial public offering of 8,625,000 shares of common stock at a public offering price of $9.00 per share, before underwriting discounts, including 1,125,000 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares at the public offering price, less the underwriting discount.
› Verified 4 days ago
Dr. Daniel D Sherbert, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5807 W Maple Rd, Ste 177, West Bloomfield, MI 48322 Phone: 248-865-6400 Fax: 248-865-6404 | |
Dr. Amy Philomena Derosa, D.O. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 33200 W 14 Mile Rd Ste 180, West Bloomfield, MI 48322 Phone: 248-688-7597 Fax: 248-498-6060 |